Navigation

Home
Investor Relations
- Corporate Overview
- Officers & Directors
- Management Team
- Stock Quote
- SEC Filings
- Press Releases
- Request Materials
Contact Us

Contact Us

Stellar Pharmaceuticals Inc.
544 Egerton St
London ON, N5W 3Z8
T: 1-800-639-0643
F: 519-434-4382

Press Releases

< 1 2 3 >

Release Date	Title (Click to read)
Dec 1, 2011	Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American Specialty Pharmaceutical Company
Nov 14, 2011	Stellar Pharmaceuticals Reports Third Quarter 2011 Financial Results
Sep 13, 2011	Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Aug 17, 2011	Stellar Pharmaceuticals Issued Uracyst(R) Patent in Japan
Aug 15, 2011	Stellar Pharmaceuticals Reports Second Quarter 2011 Financial Results
Jun 8, 2011	Stellar Pharmaceuticals Engages Advisory Consultant for Its Products in the United States Market
May 16, 2011	Stellar Pharmaceuticals Reports First Quarter 2011 Financial Results
Apr 13, 2011	Stellar Pharmaceuticals Inc. and Watson Pharmaceuticals, Inc. Terminate Uracyst(R) Supply and Licensing Agreements
Mar 31, 2011	Stellar Pharmaceuticals Profitable for 2010; Revenues Up 32% & Net Profit Up 120%
Mar 15, 2011	Stellar Pharmaceuticals Engages Seasoned Business Development Consultant
Mar 7, 2011	Stellar's Common Shares Now Trading on OTCQB
Jan 18, 2011	Stellar Pharmaceuticals Announces Retirement of Peter Riehl as CEO, President and Director
Jan 6, 2011	Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
Nov 16, 2010	Stellar Pharmaceuticals Provides Further Update on the Watson Ur008 Pilot Study of Uracyst(R)
Nov 10, 2010	Stellar Pharmaceuticals Provides Update on Watson's U.S. Pilot Study of Uracyst(R)
Nov 9, 2010	Stellar Pharmaceuticals Reports Third Quarter 2010 Financial Results
Oct 11, 2010	Stellar Pharmaceuticals Announces Completion of Non-Brokered Private Placement
Oct 5, 2010	Stellar Pharmaceuticals Announces Non-Brokered Private Placement
Aug 11, 2010	Stellar Pharmaceuticals Inc. to Present at Global Hunter Investor Conference
Aug 6, 2010	Stellar Pharmaceuticals Reports Second Quarter 2010 Financial Results

< 1 2 3 >